Listen "Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm"
Episode Synopsis
Is your patient's proteinuria low enough? New KDIGO goals: target the immune cause and hit < 0.5 g/day to preserve kidney function. Credit available for this activity expires: 12/2/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003055?ecd=bdc_podcast_libsyn_mscpedu
More episodes of the podcast Keeping Current
The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology
05/01/2026
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies
24/12/2025
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies
12/12/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.